Article
Re-thinking Alzheimer's disease therapeutic targets using gene-based tests
9 Oct 2018
Abstract excerpt
Background Alzheimer's disease (AD) is a devastating condition with no known effective drug treatments. Existing drugs only alleviate symptoms. Given repeated expensive drug failures, we assessed systematically whether approved and investigational AD drugs are targeting products of genes strongly associated with AD and whether these genes are targeted by existing drugs for other indications which could be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
